Tisacid szuszpenzió és tabletta savkötö képességének vizsgálata intragasztrikus pH-méréssel hiperacid betegekben.

B. Hunyady, A. Ciráki, A. Vincze, M. Garamszegi, L. Nagy, T. Jávor

Research output: Article

1 Citation (Scopus)

Abstract

The effect of a Hungarian Al-Mg-containing drug, called Tisacid was studied using of 2.0, 1.0 and 0.5 gram doses. Two administration forms, suspension and tablet were compared. Ten informed, adult hyperacid volunteers were included into the program and three times 5-hour intragastric pH-metry was carried out in a randomized, self-controlled open clinical study (Control, after administration of tablet or suspension). Both forms were found effective in gastric acid reduction at doses of 2.0 and 1.0 g. Tisacid suspension revealed a more pronounced efficacy at the dose of 2.0 g in comparison to the same dose of tablet form. The 0.5 g dose seemed insufficient in reduction of gastric acidity in hyperacid patients applied in tablet or suspension forms. The authors emphasize the role of continuous intragastric pH-metry in clinical practice and investigation of antacids and antisecretory drugs.

Original languageHungarian
Pages (from-to)1353-1356
Number of pages4
JournalOrvosi Hetilap
Volume135
Issue number25
Publication statusPublished - jún. 19 1994

Fingerprint

Tablets
Suspensions
Acids
Antacids
Gastric Acid
Pharmaceutical Preparations
Volunteers
Stomach

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tisacid szuszpenzió és tabletta savkötö képességének vizsgálata intragasztrikus pH-méréssel hiperacid betegekben. / Hunyady, B.; Ciráki, A.; Vincze, A.; Garamszegi, M.; Nagy, L.; Jávor, T.

In: Orvosi Hetilap, Vol. 135, No. 25, 19.06.1994, p. 1353-1356.

Research output: Article

@article{5245e828a6664b85b452ef0da633a249,
title = "Tisacid szuszpenzi{\'o} {\'e}s tabletta savk{\"o}t{\"o} k{\'e}pess{\'e}g{\'e}nek vizsg{\'a}lata intragasztrikus pH-m{\'e}r{\'e}ssel hiperacid betegekben.",
abstract = "The effect of a Hungarian Al-Mg-containing drug, called Tisacid was studied using of 2.0, 1.0 and 0.5 gram doses. Two administration forms, suspension and tablet were compared. Ten informed, adult hyperacid volunteers were included into the program and three times 5-hour intragastric pH-metry was carried out in a randomized, self-controlled open clinical study (Control, after administration of tablet or suspension). Both forms were found effective in gastric acid reduction at doses of 2.0 and 1.0 g. Tisacid suspension revealed a more pronounced efficacy at the dose of 2.0 g in comparison to the same dose of tablet form. The 0.5 g dose seemed insufficient in reduction of gastric acidity in hyperacid patients applied in tablet or suspension forms. The authors emphasize the role of continuous intragastric pH-metry in clinical practice and investigation of antacids and antisecretory drugs.",
author = "B. Hunyady and A. Cir{\'a}ki and A. Vincze and M. Garamszegi and L. Nagy and T. J{\'a}vor",
year = "1994",
month = "6",
day = "19",
language = "Hungarian",
volume = "135",
pages = "1353--1356",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "25",

}

TY - JOUR

T1 - Tisacid szuszpenzió és tabletta savkötö képességének vizsgálata intragasztrikus pH-méréssel hiperacid betegekben.

AU - Hunyady, B.

AU - Ciráki, A.

AU - Vincze, A.

AU - Garamszegi, M.

AU - Nagy, L.

AU - Jávor, T.

PY - 1994/6/19

Y1 - 1994/6/19

N2 - The effect of a Hungarian Al-Mg-containing drug, called Tisacid was studied using of 2.0, 1.0 and 0.5 gram doses. Two administration forms, suspension and tablet were compared. Ten informed, adult hyperacid volunteers were included into the program and three times 5-hour intragastric pH-metry was carried out in a randomized, self-controlled open clinical study (Control, after administration of tablet or suspension). Both forms were found effective in gastric acid reduction at doses of 2.0 and 1.0 g. Tisacid suspension revealed a more pronounced efficacy at the dose of 2.0 g in comparison to the same dose of tablet form. The 0.5 g dose seemed insufficient in reduction of gastric acidity in hyperacid patients applied in tablet or suspension forms. The authors emphasize the role of continuous intragastric pH-metry in clinical practice and investigation of antacids and antisecretory drugs.

AB - The effect of a Hungarian Al-Mg-containing drug, called Tisacid was studied using of 2.0, 1.0 and 0.5 gram doses. Two administration forms, suspension and tablet were compared. Ten informed, adult hyperacid volunteers were included into the program and three times 5-hour intragastric pH-metry was carried out in a randomized, self-controlled open clinical study (Control, after administration of tablet or suspension). Both forms were found effective in gastric acid reduction at doses of 2.0 and 1.0 g. Tisacid suspension revealed a more pronounced efficacy at the dose of 2.0 g in comparison to the same dose of tablet form. The 0.5 g dose seemed insufficient in reduction of gastric acidity in hyperacid patients applied in tablet or suspension forms. The authors emphasize the role of continuous intragastric pH-metry in clinical practice and investigation of antacids and antisecretory drugs.

UR - http://www.scopus.com/inward/record.url?scp=0028776661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028776661&partnerID=8YFLogxK

M3 - Article

C2 - 8008366

AN - SCOPUS:0028776661

VL - 135

SP - 1353

EP - 1356

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 25

ER -